I. Rabinowitz

发表

Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles.

Christian Bergemann, Kimberly S Butler, Richard S Larson, 2009, Cancer research.

Fragmentation hemolytic anemia 8 years after replacement of ascending aorta with a sutureless intraluminal graft

I. Rabinowitz, H. Sayar, C. Dietl, 2006, American journal of hematology.

Epstein–Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature

M. Vasef, I. Rabinowitz, M. Fekrazad, 2009, Journal of hematopathology.

Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine.

K. Nolte, B. Hjelle, I. Rabinowitz, 2010, American journal of clinical pathology.

Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study.

B. Zimmerman, I. Rabinowitz, B. Piper, 2006, Oncology nursing forum.

Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies

S. Eberhardt, C. Verschraegen, I. Rabinowitz, 2009, Investigational New Drugs.

The Utility of Bayes’ theorem in positron emission tomography positive suspected cases of relapsed non-Hodgkin’s lymphoma

I. Rabinowitz, Sang-Joon Lee, E. Libby, 2008 .

A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors

C. Verschraegen, A. Daud, A. Kudelka, 2009, Cancer Chemotherapy and Pharmacology.

Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells

D. Mackenzie, T. Thompson, I. Rabinowitz, 2016, PloS one.

Sorafenib-Induced Grade Four Hepatotoxicity in a Patient with Recurrent Gastrointestinal Stromal Tumor (GIST): A Case Report and Review of Literature

I. Rabinowitz, W. Murad, F. Lee, 2014, ACG case reports journal.

von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.

D. Mancuso, I. Rabinowitz, J. Sadler, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.

P. Mannucci, P. Mannucci, D. Mancuso, 1991, The Journal of clinical investigation.

Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen

I. Rabinowitz, E. Libby, Dulcinea Candelaria-Quintana, 2010, American journal of hematology.

Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen.

S. Eberhardt, C. Muller, T. Bocklage, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Alternative administration of camptothecin analogues

C. Verschraegen, I. Rabinowitz, Ursa Glaberman, 2005, Expert opinion on drug delivery.

Implementation and Results of a Test Dose Program with Taxanes

I. Rabinowitz, E. Ballard, B. Stanford, 2002, Cancer journal.

Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial

E. Sokol, R. Gutenkunst, W. Arap, 2022, medRxiv.

Interaction between statins and rituximab in non-Hodgkin's lymphoma.

I. Rabinowitz, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adhesion receptor activation of phosphatidylinositol 3-kinase. von Willebrand factor stimulates the cytoskeletal association and activation of phosphatidylinositol 3-kinase and pp60c-src in human platelets.

C. Mitchell, I. Rabinowitz, S. Jackson, 1994, The Journal of biological chemistry.

Phase II Study of Carboplatin, Vinorelbine and Capecitabine in Patients with Metastatic Breast Cancer

C. Verschraegen, I. Rabinowitz, M. Royce, 2006 .

A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer

C. Verschraegen, I. Rabinowitz, M. Royce, 2010, American journal of clinical oncology.

Does Ethnicity Influence Response To Docetaxel Based-Chemotherapy For Patients With Castration Resistant Prostate Cancer? The New Mexico Perspective.

C. Verschraegen, I. Rabinowitz, Sang-Joon Lee, 2009 .

Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib.

I. Rabinowitz, K. Shindler, J. Sadler, 1993, The Journal of biological chemistry.

Characterization of Three Mutations Causing von Willebrand Disease Type IIA in Five Unrelated Families

Pille Harrison, I. Rabinowitz, B. Brenner, 1992, Thrombosis and Haemostasis.

First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers

Matthew D. Hellmann, Joseph D. Szustakowski, Hossein Borghaei, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A patient with chronic lymphocytic leukemia and acquired angioedema: correlation of clinical and biochemical response to CLL therapy

I. Rabinowitz, GR Mohyuddin, 2013, Ecancermedicalscience.

Phase I dose finding study of carboplatin, paclitaxel, and temozolomide in advanced solid tumors

C. Verschraegen, I. Rabinowitz, A. Mangalik, 2011, Melanoma research.

Results from a phase 2 trial of bortezomib (B) and sorafenib (S) in unresectable or metastatic renal cell cancer.

M. Edelman, I. Rabinowitz, R. Lauer, 2014 .

New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami.

I. Rabinowitz, F. Civantos, J. Sadler, 1993, Blood.

Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy

I. Rabinowitz, S. Sasankan, Lorraine Rebuck, 2020, Case Reports in Oncology.

Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.

I. Rabinowitz, P. Khalili, D. Quintana, 2016, Cancer genetics.

Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols.

C. Verschraegen, I. Rabinowitz, Sang-Joon Lee, 2008, Urologic oncology.

An unusual reoccurrence of Waldenstrom's macroglobulinemia as pleural effusions that had a discordant response with treatment.

I. Rabinowitz, C. Amin, 2005, Clinical and laboratory haematology.

A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers

S. Belinsky, J. Bauman, C. Verschraegen, 2014, Translational oncology.

Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma.

P. Hraber, T. Bocklage, I. Rabinowitz, 2007, The Journal of molecular diagnostics : JMD.

Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer

V. Valero, C. Watkins, M. Cristofanilli, 2010, Clinical Cancer Research.

Tolerability/safety of sunitinib (SU) on schedule 2/1 in combination with capecitabine (C) in patients (pts) with advanced solid tumors (STs): A phase I dose-finding study

Suzanne F. Jones, L. Tye, H. Burris, 2008 .

Necrotizing fasciitis following rituximab therapy

I. Rabinowitz, J. Krieger, Jan M Merin, 2002 .

Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups

J. Bauman, R. Hromas, C. Wiggins, 2014, Leukemia & lymphoma.

Dose of prophylactic platelet transfusions did not affect bleeding incidence or severity

I. Rabinowitz, 2010, Annals of Internal Medicine.

The immune response to a fungus in pancreatic cancer samples

I. Rabinowitz, S. Cingam, C. Martínez, 2023, bioRxiv.

Octreotide Scans Are Positive in a Subset of Patients with Hepatocellular Carcinoma

I. Rabinowitz, R. Telepak, F. Lee, 2002, Clinical nuclear medicine.

A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.

R. Hromas, I. Rabinowitz, John D. Bibb, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anaplastic Large Cell Lymphoma Associated With Breast Implants

M. Vasef, I. Rabinowitz, O. Sanaei, 2012, World journal of plastic surgery.

Primary plasmacytoma arising in an endocervical polyp with detection of neoplastic cells on papanicolaou test. A case report and review of the literature.

T. Bocklage, I. Rabinowitz, D. Viswanatha, 2009, Archives of pathology & laboratory medicine.

A phase II multicenter, double-blind, randomized trial to compare anastrozole plus gefinitib with anastrozole plus placebo in postmenopausal women with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

V. Valero, C. Watkins, M. Cristofanilli, 2008 .

The Equipoise Between the Treatment of Glioblastoma and the Risk of Secondary Acute Myelogenous Leukemia: An Illustrative Case Report

I. Rabinowitz, Krishna Moturi, Moises Harari-Turquie, 2023, Journal of Investigative Medicine High Impact Case Reports.

A randomized trial assessing the utility of a test-dose program with taxanes

I. Rabinowitz, C. Jumper, E. Ballard, 2005, Current medical research and opinion.

A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer

C. Verschraegen, I. Rabinowitz, M. Royce, 2010, American journal of clinical oncology.

Phase I/II study of docetaxel (D), gemcitabine (G), and bevacizumab (B) in patients (pts) with advanced or recurrent soft tissue sarcoma (STS)

C. Muller, C. Verschraegen, I. Rabinowitz, 2007 .